These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 17123867)

  • 1. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
    Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Atar D; Huber K; Rupprecht HJ; Kopecky SL; Schwitter J; Theek C; Brandl K; Henning R; Geudelin B
    Cardiology; 2007; 108(2):117-23. PubMed ID: 17019083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
    Ross AM; Gibbons RJ; Stone GW; Kloner RA; Alexander RW;
    J Am Coll Cardiol; 2005 Jun; 45(11):1775-80. PubMed ID: 15936605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention.
    O'Neill WW; Martin JL; Dixon SR; Bartorelli AL; Trabattoni D; Oemrawsingh PV; Atsma DE; Chang M; Marquardt W; Oh JK; Krucoff MW; Gibbons RJ; Spears JR;
    J Am Coll Cardiol; 2007 Jul; 50(5):397-405. PubMed ID: 17662390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial.
    Zeymer U; Suryapranata H; Monassier JP; Opolski G; Davies J; Rasmanis G; Linssen G; Tebbe U; Schröder R; Tiemann R; Machnig T; Neuhaus KL;
    J Am Coll Cardiol; 2001 Nov; 38(6):1644-50. PubMed ID: 11704395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
    Cantor WJ; Fitchett D; Borgundvaag B; Heffernan M; Cohen EA; Morrison LJ; Ducas J; Langer A; Mehta S; Lazzam C; Schwartz B; Dzavik V; Goodman SG
    Am Heart J; 2008 Jan; 155(1):19-25. PubMed ID: 18082484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Skene A; McCabe CH; Braunwald E;
    Am Heart J; 2006 Jun; 151(6):1186.e1-9. PubMed ID: 16781216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
    Fornaro G; Lazzero M; Giacalone A; Aralda D; Prando MD; Rossi L; Bongo AS
    G Ital Cardiol (Rome); 2008 Jun; 9(6):408-20. PubMed ID: 18681392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
    Halladin NL
    Dan Med J; 2015 Apr; 62(4):B5054. PubMed ID: 25872540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Armstrong PW; Adams PX; Al-Khalidi HR; Hamm C; Holmes D; O'Neill W; Todaro TG; Vahanian A; Van de Werf F; Granger CB;
    Am Heart J; 2005 Mar; 149(3):402-7. PubMed ID: 15864228
    [No Abstract]   [Full Text] [Related]  

  • 17. Short- and long-term effects of melatonin on myocardial post-ischemic recovery.
    Lochner A; Genade S; Davids A; Ytrehus K; Moolman JA
    J Pineal Res; 2006 Jan; 40(1):56-63. PubMed ID: 16313499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
    Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; de la Torre-Hernandez JM; Gonzalez-Gonzalez J; Garcia-Camarero T; Consuegra-Sanchez L; Garcia-Saiz MD; Aldea-Perona A; Virgos-Aller T; Azpeitia A; Reiter RJ;
    J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.